About Lifecode Technologies
Lifecode Technologies is a company based in Delhi (India) founded in 2013. It operates as a B2B and Service-based Consulting. Lifecode Technologies offers products and services including CellSure, MouSure, LifeCard, and InvEx. Lifecode Technologies operates in a competitive market with competitors including Foundation Medicine, Personalis, Novogene Corporation, MedGenome and Lantern Pharma, among others.
- Headquarter Delhi, India
-
Sectors
TechnologyHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Lifecode Technologies Private Limited
- Date of Incorporation 13 Sep, 2013
- Jurisdiction New Delhi, Delhi, India
-
Annual Revenue
$15.28 K (USD)0as on Mar 31, 2017
-
Net Profit
-$12.43 K (USD)0as on Mar 31, 2017
-
EBITDA
-$8.88 K (USD)0as on Mar 31, 2017
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Lifecode Technologies
Lifecode Technologies offers a comprehensive portfolio of products and services, including CellSure, MouSure, LifeCard, and InvEx.
Service for characterizing cell lines in genomics research applications.
Service for analyzing mouse genetics in research and diagnostics.
Card providing personalized genome diagnostics for precision medicine.
Service for sequencing exomes in genetic research investigations.
Funding Insights of Lifecode Technologies
Detailed funding history for Lifecode Technologies
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lifecode Technologies
Investment portfolio details for Lifecode Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Lifecode Technologies
Detailed financials for Lifecode Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lifecode Technologies Comparisons
Peer comparison for Lifecode Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lifecode Technologies
Lifecode Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Foundation Medicine, Personalis, Novogene Corporation, MedGenome and Lantern Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Genomic sequencing and diagnosis software is provided for healthcare.
|
|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
DNA sequencing, bioinformatics, and multiomics services are provided.
|
|
| Locked | Locked | Locked |
Drug and companion diagnostics for multi-drug resistant cancers are developed.
|
|
| Locked | Locked | Locked |
Personalized cancer diagnostics are developed using genomic big data analysis.
|
Detailed competitors of Lifecode Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lifecode Technologies
Complete news archive for Lifecode Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lifecode Technologies
Lifecode Technologies was founded in 2013.
Lifecode Technologies is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Annual revenue of Lifecode Technologies is $15.28K as on Mar 31, 2017.
Lifecode Technologies is a company specializing in clinical genomics, offering advanced NGS analysis, personalized genome diagnostics, and research consultancy services. They develop custom panels for genetic diagnostics and provide products like CellSure for cell line characterization. Based in New Delhi, India, they support the life-cycle of genomics concepts through analytics and services for research and healthcare sectors. Their focus includes high-quality genetic testing and consultancy without specifying client details.
Lifecode Technologies's top competitors include Foundation Medicine, MedGenome and Personalis.
Lifecode Technologies offers CellSure, MouSure, LifeCard, and InvEx.